Sandbox vidit3
New
Click on boxes to expand/collapse detailed information.
|
❑ Prodrome:
❑ Chest pain (suggestive of cardiovascular syncope)
❑ Activity prior to LOC: (suggestive of cardiovascular or reflex syncope)
❑ Bowel or bladder incontinence (suggestive of reflex syncope) |
Inquire about medications intake: |
| style="width: 100%; font-size: 100%;" valign=top |
Obtain a detailed past medical history:
❑ Previously healthy
❑ Previous syncope episodes
- ❑ Time since previous episode
- ❑ Number of previous episodes
❑ Cardiovascular disease:
- ❑ Arrhythmia
- ❑ Heart block (LBBB, RBBB)
- ❑ Valvular heart disease
- ❑ Heart failure
- ❑ Hypertrophic cardiomyopathy
- ❑ Cardiac tumor
❑ Neurological diseases:
❑ Metabolic disorders (diabetes) ❑ Recent trauma
|}
| style="width: 100%; font-size: 100%;" valign=top |
Identify possible triggers:
Suggestive of reflex syncope
❑ Emotional stress
❑ Crowded places (agoraphobia)
❑ Warm weather
❑ Prolonged standing
❑ Cough
❑ Micturition
❑ Defecation
❑ Swallowing
❑ Head motion
❑ Arm motion
❑ Shaving
Suggestive of cardiovascular or orthostatic hypotension
❑ Trauma
❑ Change in position
❑ Fatigue
❑ Exertion
|}
| style="width: 100%; font-size: 100%;" valign=top |
Examine the patient
Vitals
❑ Heart rate
- ❑ Irregular rhythm (suggestive of AF)
- ❑ Tachycardia (suggestive of orthostatic hypotension, cardiovascular or reflex syncope)
- ❑ Bradycardia (suggestive of cardiovascular syncope)
- ❑ Measure in both arms, while standing and supine
- ❑ Orthostatic hypotension (Fall in systolic BP ≥ 20 mmHg and/or in diastolic BP of at least≥ 10 mmHg between the supine and sitting BP reading)
- ❑ Hypertension (suggestive of cardiovascular syncope)
- ❑ Tachypnea (suggestive of reflex syncope)
Respiratory
❑ Rales (suggestive of HF)
Cardiovascular
❑ Palpitations (suggestive of arrhythmia)
❑ Carotid bruits (suggestive of cardiovascular syncope)
❑ Murmurs:
- ❑ Aortic stenosis: crescendo-decrecendo systolic ejection murmur best heard at the upper right sternal border
- ❑ Pulmonary stenosis: systolic ejection murmur best heard at the left second intercostal space
- ❑ Loud P2 (suggestive of pulmonary hypertension)
Neurologic
❑ Focal abnormalities (suggestive of stroke or cerebral mass)
- ❑ Hemiparesis
- ❑ Vision loss
- ❑ Aphasia
- ❑ Hypertonia
❑ Glasgow coma scale
❑ Signs suggestive of Parkinson's disease:
- ❑ Tremor
- ❑ Rigidity
- ❑ Bradykinesia/Akinesia
- ❑ Postural instability
- ❑ Shuffling gait
|}
| style="width: 100%; font-size: 100%;" valign=top |
|}
| style="width: 100%; font-size: 100%;" valign=top |
|}
| style="width: 100%; font-size: 100%;" valign=top |
|}
| style="width: 100%; font-size: 100%;" valign=top |
|}
Drug | Adult dosage |
---|---|
Inhaled Short Acting β Agonists (SABA) | |
Albuterol/Bitolterol/Pirbuterol a) Nebulizer solution b) MDI | ♦ 2.5-5 mg every 20 minutes for 3 doses, then 2.5-10 mg every 1-4 hours as needed or 10-15 mg/hour continuously. ♦ 4-8 puffs every 20 mins upto 4 hours, then every 1-4 hours as needed. |
Levalbuterol a) Nebulizer solution b) MDI | ♦ 1.25-2.5 mg every 20 mins for 3 doses, then 1.25-5 mg every 1-4 hours as needed. ♦ 4-8 puffs every 20 mins upto 4 hours, then every 1-4 hours as needed. |
Anticholinergics | |
Ipratropium bromide a) Nebulizer solution b) MDI | ♦ 0.5 mg every 20 mins for 3 doses, then as needed. ♦ 8 puffs every 20 mins as needed for upto 3 hours. |
Ipratropium with albuterol a) Nebulizer solution (each 3 ml containing 0.5 mg ipratropium and 2.5 mg albuterol) b) MDI (each puff contains 18 mcg ipratropium and 90 mcg albuterol) | ♦ 3 ml every 20 mins for 3 doses, then as needed. ♦ 8 puffs every 20 mins as needed for 3 hours |
Systemic corticosteroids | |
Prednisone/Prednisolone/Methylprednisolone | ♦ 40-80 mg/day in 1 or 2 divided doses until peak expiratory flowrate (PEF) reaches 70% of personal best. |
Clinical course | Unstable |
---|---|
Physical examination | Signs of heart failure |
Functional class | IV |
6MWD | Less than 400 m |
Echocardiogram | RV Enlargement |
Hemodynamics | RAP high CI low |
BNP | Elevated/Increasing |
Treatment | Intravenous prostacyclin and/or combination treatment |
Frequency of evaluation | Q 1 to Q 3 months |
FC assessment | Every clinic visit |
6MWT | Every clinic visit |
Echocardiogram2 | Q 6 to Q 12 months/center dependent |
BNP | center dependent |
RHC | Q 6 to Q 12 months or clinical deterioration |